|
|
Volumn 8, Issue 2, 2008, Pages 124-131
|
|
Tumor necrosis factor: Renaissance as a cancer therapeutic?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
CYSTEINYLASPARAGINYLGLYCYLARGINYLCYSTEINE;
DACTINOMYCIN;
DOXORUBICIN;
MELPHALAN;
PEPTIDE DERIVATIVE;
RECOMBINANT GAMMA INTERFERON;
RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
VIRUS VECTOR;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CYTOLOGY;
DRUG EFFICACY;
DRUG MECHANISM;
EDEMA;
HUMAN;
HYPOTENSION;
KIDNEY CARCINOMA;
LIMB PERFUSION;
LIVER TOXICITY;
MELANOMA;
MULTIPLE MYELOMA;
MUSCLE DISEASE;
NONHUMAN;
REVIEW;
SIGNAL TRANSDUCTION;
SOFT TISSUE SARCOMA;
TUMOR;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
HUMANS;
NEOPLASMS;
TUMOR NECROSIS FACTORS;
|
|
EID: 40449134499
PISSN: 15680096
EISSN: None
Source Type: Journal
DOI: 10.2174/156800908783769346 Document Type: Review |
|
Times cited : (45)
|
|
References (158)
|
